12,020 Shares of BrightSpring Health Services, Inc. $BTSG Acquired by Summit Global Investments

Summit Global Investments bought a new stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,020 shares of the company’s stock, valued at approximately $682,000.

Several other institutional investors have also modified their holdings of the company. Allworth Financial LP bought a new position in BrightSpring Health Services in the 2nd quarter worth approximately $28,000. Root Financial Partners LLC bought a new stake in BrightSpring Health Services during the 3rd quarter valued at $25,000. IFP Advisors Inc raised its stake in BrightSpring Health Services by 204.5% during the 2nd quarter. IFP Advisors Inc now owns 606 shares of the company’s stock valued at $42,000 after acquiring an additional 407 shares in the last quarter. Kilter Group LLC acquired a new position in BrightSpring Health Services during the 2nd quarter worth $50,000. Finally, Public Employees Retirement System of Ohio acquired a new position in BrightSpring Health Services during the 2nd quarter worth $63,000.

Trending Headlines about BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Strong Q3 performance and higher guidance: BrightSpring’s third-quarter earnings reportedly rose 80%, with pharmacy and home health growth driving a revenue beat and margin expansion. Management also raised its 2026 outlook and highlighted potential for continued organic growth in 2027, supported by specialty drug launches and home health gains. BrightSpring Q3 Earnings Beat on Specialty Growth, 2026 View Raised
• Positive Sentiment: Analysts raised price targets: Leerink Partners increased its target from $72 to $92 and assigned an “outperform” rating. TD Cowen raised its target from $81 to $84 and issued a “buy” rating, while Wells Fargo lifted its target from $78 to $82 and maintained an “overweight” rating. These revisions signal increased confidence in BrightSpring’s earnings growth and business momentum. Leerink Partners BrightSpring Ratings TD Cowen BrightSpring Ratings Wells Fargo BrightSpring Ratings
• Positive Sentiment: Improved consensus sentiment: Wall Street Zen upgraded BTSG to “strong-buy,” adding to the favorable analyst commentary surrounding the earnings report. Wall Street Zen Upgrades BrightSpring to Strong-Buy

BrightSpring Health Services Price Performance

Shares of NASDAQ:BTSG opened at $66.26 on Tuesday. BrightSpring Health Services, Inc. has a one year low of $30.64 and a one year high of $73.75. The stock has a fifty day moving average of $60.09 and a 200-day moving average of $54.68. The company has a market capitalization of $13.11 billion, a PE ratio of 35.82, a price-to-earnings-growth ratio of 0.77 and a beta of 1.87. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.22 and a current ratio of 1.59.

BrightSpring Health Services (NASDAQ:BTSG) last issued its earnings results on Friday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. The business had revenue of $4.21 billion for the quarter, compared to analysts’ expectations of $3.88 billion. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%. BrightSpring Health Services’s revenue was up 26.4% compared to the same quarter last year. As a group, equities analysts anticipate that BrightSpring Health Services, Inc. will post 1.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on BTSG shares. BTIG Research reissued a “buy” rating and issued a $90.00 price target on shares of BrightSpring Health Services in a research note on Thursday, August 13th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $70.00 price objective on shares of BrightSpring Health Services in a research note on Monday, August 3rd. Leerink Partners upped their price objective on shares of BrightSpring Health Services from $72.00 to $92.00 and gave the stock an “outperform” rating in a report on Monday. The Goldman Sachs Group reissued a “buy” rating and set a $90.00 target price on shares of BrightSpring Health Services in a research note on Monday. Finally, KeyCorp reiterated an “overweight” rating on shares of BrightSpring Health Services in a research report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $77.62.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.